Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Operating Margin: 2019-2025

Historic Operating Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -6.07%.

  • Eton Pharmaceuticals' Operating Margin fell 1100.00% to -6.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -4.89%, marking a year-over-year increase of 424.00%. This contributed to the annual value of -6.66% for FY2024, which is 289.00% down from last year.
  • Eton Pharmaceuticals' Operating Margin amounted to -6.07% in Q3 2025, which was up 22.12% from -7.79% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Operating Margin ranged from a high of 45.08% in Q1 2021 and a low of -754.45% during Q3 2021.
  • In the last 3 years, Eton Pharmaceuticals' Operating Margin had a median value of -7.79% in 2025 and averaged -9.28%.
  • Examining YoY changes over the last 5 years, Eton Pharmaceuticals' Operating Margin showed a top increase of 2,261,419bps in 2021 and a maximum decrease of 24,731,177bps in 2021.
  • Eton Pharmaceuticals' Operating Margin (Quarterly) stood at 21.57% in 2021, then crashed by 907bps to 12.50% in 2022, then crashed by 1,918bps to -6.69% in 2023, then surged by 1,209bps to 5.40% in 2024, then tumbled by 1,100bps to -6.07% in 2025.
  • Its Operating Margin stands at -6.07% for Q3 2025, versus -7.79% for Q2 2025 and -26.32% for Q1 2025.